A parliamentary inquiry into approval processes for new drugs and novel medical technologies has again raised the issue of how patients with rare sleep disorders such as narcolepsy are managed in Australia. A public hearing of the Inquiry heard consumers are frustrated at all stages of the process. For example, they report confusion about why ...
Patient frustration aired as narcolepsy falls between the respiratory-neurology specialty gaps
By Mardi Chapman
7 Jun 2021